On a recent episode of the Joe Rogan Experience podcast, guest Bridget Phetasy raised eyebrows by questioning the treatment received by President Joe Biden amidst his ongoing health issues. The conversation took a turn towards speculation and controversy as Phetasy queried whether Biden had indeed been administered 10 doses of Paxlovid, a medication used to treat COVID-19.
The discussion began with Phetasy’s reference to Biden’s earlier statements where he had indicated he would not be resigning or quitting his position. She highlighted a shift in Biden’s stance following his diagnosis with COVID-19, suggesting a significant and mysterious change in his condition. Phetasy’s comments drew attention to the unusual nature of the situation, especially in light of reports claiming that Biden had received an unusually high number of Paxlovid doses.
“Well, there’s been a lot of weird stuff,” Phetasy remarked. “We haven’t seen him since then. Right, and then he gets COVID, and then all of a sudden he says he can’t. And they also said that they gave him 10 doses of Paxlovid. Is that true, Google?”
The assertion that Biden might have received 10 doses of Paxlovid has raised several questions and stirred a wave of speculation. Critics argue that such a high dosage seems inconsistent with standard treatment protocols. Phetasy’s remarks also hinted at the possibility of misinformation, suggesting that claims might be part of a broader disinformation campaign, potentially fueled by foreign entities or “Russian trolls” looking to create confusion and discord.
In response to Phetasy’s claims, the White House has not yet provided a detailed clarification on Biden’s treatment regimen. The lack of official information has only fueled further speculation and debate.
As the story continues to develop, the controversy highlights ongoing concerns about transparency and the dissemination of information regarding high-profile figures’ health. With the public increasingly wary of misinformation, the call for accurate and timely updates from official sources remains as crucial as ever.
